Futura Medical PLC (OTCPK:FAMDF)
$ 0.381 -0.034 (-8.19%) Market Cap: 120.65 Mil Enterprise Value: 115.75 Mil PE Ratio: 0 PB Ratio: 10.38 GF Score: 41/100

Full Year 2018 Futura Medical PLC Earnings Call Transcript

Apr 10, 2019 / 09:00AM GMT
Release Date Price: $0.25
James Henry Barder
Futura Medical plc - CEO & Executive Director

Okay, well, first of all, I'd like to thank you all for joining Futura's prelim webcast this morning, analyst meeting, and also thank those that are listening to the webcast. I'm joined today by Ken James, who's Executive Head of R&D; and also by Angela Hildreth, who's the Finance Director and Chief Operating Officer of Futura.

If you want to turn to Slide 5. And it showed a corporate overview about Futura. We're obviously listed on AIM, and we describe ourselves as a virtual organization with 15 staff and a low overhead base. We have a significant outsourced infrastructure with over 30 consultants. Dermasys is our key sort of asset. It's our transdermal delivery system, which enables existing pharmaceutical drugs for improved or new indications. We don't, at this stage, look at new clinical indications so it does derisk the process. We've got an excellent safety profile -- the Dermasys system has an excellent safety profile with no harsh permeation enhancers.

Our track record is we're very good at clinically

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot